510(k) device
Niox Mino Model 09-1000
Aerocrine AB · System, Test, Breath Nitric Oxide (MXA, Class II) · First FDA decision Mar 3, 2008, newest Sep 2, 2010Asthma
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
9
Naming "Niox Mino"
MAUDE reports
0
Brand "Niox Mino", since 2015
PubMed studies
103
Mentioning "Niox Mino"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- NIOX MINO MODEL 09-1000510(k)
K101034 · Decided Sep 2, 2010 · 141 days after receipt
Device type: System, Test, Breath Nitric Oxide (MXA) · Laboratory Medicine & Pathology
- NIOX MINO510(k)
K072816 · Decided Mar 3, 2008 · 153 days after receipt
Device type: System, Test, Breath Nitric Oxide (MXA) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Niox Mino", any status and sponsor, newest update first.
- Optimization of Inhaled Corticosteroid Treatment in Adult Patients With Asthma Guided by Exhaled NO Measurement at HomePivotal-lookingTerminated
Orion Corporation, Orion PharmaNot on our public-company list
NCT01783132 · 142 participants · Start Dec 1, 2012 · Primary completion Apr 1, 2014
Device: NIOX MINO · For: Asthma
Sites: Uppsala, Sweden
Tufts Medical CenterAcademic, hospital or other
NCT01170234 · 14 participants · Start Aug 2010 · Primary completion Feb 2012
Device: NIOX MINO® Airway Inflammation Monitor · For: Eosinophilic Esophagitis
Sites: Boston, Massachusetts
Wake Forest UniversityAcademic, hospital or other
NCT01761006 · 10 participants · Start Mar 2013 · Primary completion Sep 23, 2014
Device: NIOX MINO® · For: Chronic Obstructive Pulmonary Disease
Sites: Winston-Salem, North Carolina
Research in Real-Life LtdResearch network
NCT02140684 · 400 participants (planned) · Start Mar 2012 · Primary completion Jan 2015
Device: eNO monitoring · For: Asthma
Sites: Cambridge, United Kingdom
Aerocrine ABNot on our public-company list
NCT01648920 · 50 participants · Start Jun 2012 · Primary completion Nov 2012
Device: NIOX MINO® Instrument (09-1100) · For: Asthma
Sites: Blue Bell, Pennsylvania; Collegeville, Pennsylvania; Doylestown, Pennsylvania · 8 sites in all
Aerocrine ABNot on our public-company list
NCT01729247 · 50 participants · Start Oct 2012 · Primary completion Nov 2012
Device: NIOX MINO® Instrument (09-1100) · For: Asthma
Sites: Raleigh, North Carolina
Aerocrine ABNot on our public-company list
NCT01634620 · 200 participants · Start Jun 2012 · Primary completion Oct 2012
Device: NIOX MINO® Instrument (09-1100) · For: Chronic Obstructive Pulmonary Disease (COPD)
Sites: Chapel Hill, North Carolina; Sanford, North Carolina
Aerocrine ABNot on our public-company list
NCT01518322 · 235 participants · Start Nov 2011 · Primary completion Feb 2012
Device: NIOX MINO® · For: Asthma
Sites: Byron, Minnesota; Chatfield, Minnesota; Pine Island, Minnesota · 13 sites in all
- Study of Monitoring Exhaled NO in Symptomatic Asthmatic Adults and Children During Anti-inflammatory TreatmentPivotal-lookingCompleted
Aerocrine ABNot on our public-company list
NCT00388570 · 151 participants · Start Oct 2006 · Primary completion Jun 2007
Device: The Aerocrine NIOX MINO® Airway Inflammation Monitor · For: Asthma
Sites: Höllviken, Sweden; Aberdeen, United Kingdom
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Niox Mino", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MXA
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Niox Mino"[tiab]. The summary above synthesizes these.
- Niox and Niox Mino: comparison of exhaled NO in grass pollen allergic adult volunteers.
Chen W, Purohit A, Barnig C, et al. · Allergy · 2007Comparative Study
- Feasibility of nasal NO screening in healthy newborns.
Buechel F, Usemann J, Aline A, et al. · Pediatr Pulmonol · 2022Research Support, Non-U.S. Gov't
- An economic evaluation of NIOX MINO airway inflammation monitor in the United Kingdom.
Price D, Berg J, Lindgren P · Allergy · 2009Research Support, Non-U.S. Gov't
- Hand-held nitric oxide sensor NIOX MINO® for the monitoring of respiratory disorders.
Maniscalco M, Lundberg JO · Expert Rev Respir Med · 2010Review
- Comparison of exhaled nitric oxide measurements between NIOX MINO electrochemical and Ecomedics chemiluminescence analyzer.
Boot JD, de Ridder L, de Kam ML, et al. · Respir Med · 2008Comparative Study, Validation Study
- Are exhaled nitric oxide measurements using the portable NIOX MINO repeatable?
Selby A, Clayton B, Grundy J, et al. · Respir Res · 2010Research Support, Non-U.S. Gov't, Validation Study
- Bio-inspired nano-engineered strip for semiquantitative FeNO analysis.
Shende P, Vaidya J, Kulkarni YA · J Breath Res · 2019
- Exhaled and Nasal Nitric Oxide - Impact for Allergic Rhinitis.
Antosova M, Bencova A, Mokra D, et al. · Physiol Res · 2020
- Can we use portable nitric oxide analyzer in young children?
Kalliola S, Malmberg P, Rito T, et al. · Pediatr Pulmonol · 2011Comparative Study
- Comparison of two exhaled nitric oxide analyzers: the NIOX MINO hand-held electrochemical analyzer and the NOA280i stationary chemiluminescence analyzer.
Kim SH, Moon JY, Kwak HJ, et al. · Respirology · 2012Comparative Study, Research Support, Non-U.S. Gov't
- Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and NObreath.
Harnan SE, Tappenden P, Essat M, et al. · Health Technol Assess · 2015Research Support, Non-U.S. Gov't, Systematic Review
- Evaluation of Fractional Exhaled Nitric Oxide in Pediatric Asthma and Allergic Rhinitis.
Jang YY, Ahn JY · Children (Basel) · 2020
Other devices of this type
Also filed under product code MXA.
- NIOX VERO Airway Inflammation MonitorAerocrine AB · 510(k) 2015
- Fenom Flo FeNO Monitoring SystemMgc Diagnostics Corporation · 510(k) 2025
- Vivatmo pro-SBosch Healthcare Solutions GmbH · 510(k) 2025
- Vivatmo proBosch Healthcare Solutions GmbH · 510(k) 2024
- Fenom ProCaire Diagnostics, Inc. · 510(k) 2023
- NObreath®Bedfont Scientific, Ltd. · 510(k) 2021
- Fenom Pro Nitric Oxide TestSpirosure, Inc. · 510(k) 2019
- Niox VeroCircassia AB · 510(k) 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.